Major Milestone for Sinofn Group
On November 21, 2025, Sinofn Group achieved a significant R&D milestone: its two FSMP (Foods for Special Medical Purposes) products dedicated to Phenylketonuria (PKU) — EnRuiYou and EnBoYou — officially passed the Chinese FSMP national registration on‑site inspection.

This successful review is not only an authoritative certification of product quality but also carries profound industry and market significance. It marks Sinofn Group’s fulfillment of its solemn commitment to provide “all‑age” PKU nutrition solutions, achieving full life‑cycle coverage from infancy to adulthood. Importantly, it breaks the long‑standing monopoly of foreign brands in this field and elevates the company’s strategic positioning in medical nutrition.
Building a Full Life‑Cycle Management System for PKU Patients
Sinofn Group has now established a scientific management system covering PKU patients across all age groups:

| Age Group | Product | Focus |
|---|---|---|
| Infants (0–12 months) | EnRuiYou | FSMP for amino acid metabolism disorders in infants |
| Children (1–10 years) | EnBoYou | FSMP tailored for amino acid metabolism disorders in children |
| Adolescents & Adults (10+ years) | EnZhuoYou + PKU low‑protein series | Specialized low‑protein formulas for long‑term PKU management |
These three phenylalanine‑free FSMP powders are scientifically formulated based on Sinofn’s years of professional nutrition management experience. Their core mission is to ensure that PKU children can enjoy a healthy and joyful start in life, just like their peers.
Strong Capabilities Driving Quality and Innovation
Behind this achievement lies Sinofn Group’s:
-
Robust independent R&D capacity
-
International‑standard manufacturing systems
-
Rigorous and precise quality inspection capabilities
During the review, the company’s scientific research, production compliance, and quality control were highly recognized by the expert panel. This demonstrates that Sinofn not only meets the strict regulatory standards for FSMP but also has the ability to consistently and stably supply high‑quality products such as EnRuiYou and EnBoYou.
By safeguarding the health and quality of life of rare disease patients, Sinofn Group is leading the way for domestic FSMP innovation and development, marking a new chapter in China’s medical nutrition journey.
Media Contact
Company Name: Sinofn (Tianjin) Pharm-Tech Co., Ltd.
Email: Send Email
Phone: 022-24928910
Address:No. 60 Weiliu Road, Airport Zone
City: Tianjin, 300308
Country: China
Website: https://www.sinofnhealth.com/